By Anusha Gopalam, Noha Soror & 4 more. Our case involved a 64-year-old man who presented with gross hematuria with clots, dysuria, and suprapubic discomfort two weeks after receiving CAR T-cell therapy for relapsed mantle cell lymphoma.
Gopalam et al. (Mon,) studied this question.